V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210036844 | 210011639 | 1.79 | 29 | Disease modification (D) | 2018-07-11 | 2018-07-11 | Chlorambucil | N | N | 210030435 | CHLORAMBUCIL |
| 210036845 | 210011726 | 1.61 | null | Curative (C) | 2017-01-05 | 2017-07-14 | ALL Int Guide A/B/C Maint Ph V | 2 | null | 210031008 | ALL INTERIM GUIDELINES |
| 210036846 | 210011734 | null | 90 | Curative (C) | 2016-11-17 | 2017-09-22 | Chlorambucil | N | N | 210031025 | CHLORAMBUCIL |
| 210036847 | 210011767 | 1.78 | 19.2 | Curative (C) | 2016-05-18 | 2016-05-31 | Chlorambucil | N | N | 210031164 | CHLORAMBUCIL |
| 210036848 | 210027514 | 0 | 19.5 | Curative (C) | 2018-06-02 | 2018-06-02 | MERCAPTOPURINE + METHOTREXATE | 99 | null | 210031465 | MERCAPTOPURINE + METHOTREXATE |
| 210036849 | 210011826 | 1.86 | 70 | Disease modification (D) | 2018-07-23 | 2018-07-31 | CHOP R - 21 days | Y | N | 210031507 | CHOP R |
| 210036851 | 210021565 | 1.87 | 82 | Curative (C) | 2019-06-19 | 2019-06-21 | CHLORAMBUCIL + prednisolone | 01 | N | 210031749 | CHLORAMBUCIL |
| 210036852 | 210011890 | 1.9 | 10.7 | Disease modification (D) | 2016-12-19 | 2016-12-19 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | N | 210031811 | UKALLR3 |
| 210036853 | 210011922 | 1.72 | 55.6 | Curative (C) | 2016-08-04 | 2017-04-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 210032019 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210036854 | 210011927 | null | 72 | Curative (C) | 2014-03-10 | 2014-03-18 | Alemtuzumab(INTRAVENOUS) | N | N | 210032021 | ALEMTUZUMAB |
| 210036856 | 210012011 | null | 82 | Curative (C) | 2017-06-24 | 2017-06-25 | Mercaptopurine | N | N | 210032638 | MERCAPTOPURINE |
| 210036857 | 210012019 | 1.77 | 15.3 | Curative (C) | 2013-06-04 | 2015-02-25 | ALL Int Guide A/B/C Maint Ph V | N | N | 210032683 | ALL INTERIM GUIDELINES |
| 210036858 | 210012092 | 1.52 | 100.5 | Disease modification (D) | 2019-10-09 | 2019-10-17 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 210032998 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210036859 | 210012141 | 1.87 | 65 | Curative (C) | 2014-08-31 | 2014-10-12 | MERCAPTOPURINE + METHOTREXATE | N | N | 210033299 | MERCAPTOPURINE + METHOTREXATE |
| 210036860 | 210012156 | 1.76 | 20.7 | Palliative (P) | 2016-06-07 | 2016-06-07 | ALL ALLR3 FLAD Phase IV | N | null | 210033375 | UKALLR3 |
| 210036861 | 210012194 | 1.66 | null | null | 2018-11-11 | 2018-11-11 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | null | 210033503 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210036862 | 210021758 | 1.8 | 100.5 | Curative (C) | 2018-10-10 | 2018-10-10 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 210033652 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210036863 | 210012240 | 1.73 | 49.5 | Curative (C) | null | 2016-02-24 | ALL Int Guide A/B/C Maint Ph V | N | N | 210033764 | ALL INTERIM GUIDELINES |
| 210036864 | 210012254 | null | 78.6 | Curative (C) | 2016-06-06 | 2016-08-18 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | 02 | N | 210033792 | UKALLR3 |
| 210036865 | 210021790 | 1.7 | 101.3 | Palliative (P) | 2018-07-17 | 2018-07-17 | CARBOPLATIN + ETOPOSIDE | N | N | 210033859 | BENDAMUSTINE |
| 210036866 | 210021792 | 1.45 | 76.5 | Not known (9) | 2016-07-26 | 2016-07-26 | PONATINIB | N | null | 210033868 | METHOTREXATE HIGH DOSE |
| 210036867 | 210012279 | null | 83.9 | Radical (R) | 2013-06-06 | 2013-11-20 | Pentostatin | Y | N | 210033900 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210036868 | 210012293 | 1.67 | 55.6 | Curative (C) | 2020-01-20 | 2020-01-20 | Dasatinib | Y | N | 210033985 | DASATINIB |
| 210036869 | 210021807 | null | null | Curative (C) | 2019-03-02 | 2019-05-04 | LOMUSTINE + PROCARBAZINE | Y | N | 210034017 | LOMUSTINE + PROCARBAZINE |
| 210036870 | 210012302 | 1.56 | 14.3 | Curative (C) | 2017-12-29 | 2018-01-04 | Cyclophosphamide+Fludara+TBI Allo | 2 | N | 210034037 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210036871 | 210012319 | 1.85 | null | Palliative (P) | 2017-07-10 | 2018-01-24 | Dasatinib | 02 | N | 210034115 | DASATINIB |
| 210036872 | 210027704 | 1.74 | 80.3 | Curative (C) | 2020-05-16 | 2020-09-02 | RIALTO TRIAL | N | N | 210034173 | METHOTREXATE HIGH DOSE |
| 210036873 | 210012342 | null | 80.3 | Curative (C) | 2018-08-27 | 2019-03-21 | IDELALISIB | Y | N | 210034234 | INOTUZUMAB OZOGAMICIN |
| 210036874 | 210012351 | 1.89 | 68.6 | Curative (C) | 2018-03-07 | 2018-03-21 | Erwinase (Erwinia Asparaginase) | N | N | 210034345 | METHOTREXATE HIGH DOSE |
| 210036875 | 210012353 | 1.7 | 75 | Curative (C) | 2017-10-16 | 2017-12-25 | Bevacizumab 10mg/kg | N | N | 210034354 | PENTOSTATIN |
| 210036876 | 210012374 | 1.55 | 53.2 | Disease modification (D) | 2017-04-11 | 2017-05-08 | LOMUSTINE + PROCARBAZINE | null | N | 210034516 | LOMUSTINE + PROCARBAZINE |
| 210036877 | 210021855 | 1.71 | 87.9 | Curative (C) | 2017-01-22 | 2017-01-22 | LOMUSTINE + PROCARBAZINE | 02 | N | 210034567 | LOMUSTINE + PROCARBAZINE |
| 210036878 | 210012396 | 1.48 | 101.3 | null | 2019-11-07 | 2019-11-08 | CYCLOPHOSPHAMIDE | N | N | 210034702 | CYCLOPHOSPHAMIDE |
| 210036879 | 210027733 | 0 | null | Curative (C) | 2018-05-14 | 2018-11-12 | Dasatinib | Y | N | 210034764 | DASATINIB |
| 210036880 | 210012415 | 1.72 | 24.4 | Adjuvant (A) | 2018-06-19 | 2018-06-19 | Cyclophosphamide Fludarabine (Oral) | 2 | N | 210034801 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210036881 | 210021887 | 1.72 | 54.5 | Palliative (P) | 2017-07-12 | 2017-11-29 | Methotrexate High Dose (3g/m2) | N | N | 210034995 | CHLORAMBUCIL + OFATUMUMAB |
| 210036883 | 210021917 | 1.83 | 22 | Adjuvant (A) | 2019-01-31 | 2019-06-19 | Dasatinib | N | N | 210035459 | DASATINIB |
| 210036884 | 210012532 | 1.85 | 71.6 | Curative (C) | 2020-03-19 | 2020-03-22 | Bendamustine +/- Prednisolone | N | N | 210035764 | METHOTREXATE HIGH DOSE |
| 210036885 | 210012566 | 1.71 | 58.7 | Curative (C) | 2019-07-03 | 2019-11-28 | Carboplatin + Etoposide iv&po | N | N | 210035996 | BENDAMUSTINE |
| 210036886 | 210012570 | 1.6 | 70.6 | Curative (C) | 2017-09-01 | 2017-10-10 | CARBOPLATIN + VINCRISTINE | Y | Y | 210036039 | CARBOPLATIN + VINCRISTINE |
| 210036887 | 210012599 | 1.77 | null | Palliative (P) | 2015-08-31 | 2016-05-27 | IDELALISIB | N | N | 210036356 | BENDAMUSTINE |
| 210036888 | 210021978 | 0 | 59.5 | Curative (C) | 2017-10-31 | 2017-10-31 | UKALL XII Maintenance (3 months) | Y | N | 210036393 | RIALTO TRIAL |
| 210036889 | 210012645 | 1.9 | 77 | Palliative (P) | 2019-05-11 | 2019-06-09 | CARBOPLATIN + VINCRISTINE | Y | null | 210036653 | CARBOPLATIN + VINCRISTINE |
| 210036890 | 210022021 | 1.83 | 97.5 | Curative (C) | 2016-08-28 | 2016-08-29 | Dasatinib | N | N | 210036863 | DASATINIB |
| 210036892 | 210012734 | 1.85 | 35 | Disease modification (D) | 2018-07-01 | 2018-07-07 | RIALTO TRIAL | N | N | 210037156 | NELARABINE |
| 210036893 | 210012765 | 1.76 | 22.9 | Adjuvant (A) | 2016-04-25 | 2019-06-15 | Procarbazine | 02 | N | 210037304 | PROCARBAZINE |
| 210036894 | 210022063 | null | null | Palliative (P) | 2019-08-31 | 2019-09-10 | LOMUSTINE + PROCARBAZINE | 2 | N | 210037339 | LOMUSTINE + PROCARBAZINE |
| 210036895 | 210022068 | 1.85 | 71.5 | Adjuvant (A) | 2014-07-10 | 2014-07-18 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | Y | 210037370 | CVP |
| 210036896 | 210012824 | null | 67.8 | Adjuvant (A) | 2015-05-30 | 2015-06-04 | RCEOP | 2 | N | 210037525 | AZACITIDINE |
| 210036897 | 210012827 | 1.46 | 19.3 | Curative (C) | 2015-03-28 | 2015-04-24 | Bevacizumab + LOMUSTINE | N | N | 210037527 | BEVACIZUMAB + TEMOZOLOMIDE |